IL1B and COVID-19: COVID-19 is characterized by a dysregulated immune response, leading to the excessive release of pro-inflammatory cytokines such as IL-1β, IL-6, and TNF-α, which contribute to tissue injury and multiorgan dysfunction [22,23,24].